About Denovium
Denovium is a company based in San Diego (United States) founded in 2018 by Imad Ajjawi was acquired by AbSci in January 2021.. Denovium offers products and services including Integrated Drug Creation Platform, AI Drug Creation, and AI Target Discovery. Denovium operates in a competitive market with competitors including Zephyr AI, Precisionlife, Chemify, Transaction Data Systems and RevolKa, among others.
- Headquarter San Diego, United States
- Founders Imad Ajjawi
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Absci Corp
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Denovium
Denovium offers a comprehensive portfolio of products and services, including Integrated Drug Creation Platform, AI Drug Creation, and AI Target Discovery. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI platform for designing and optimizing biologics to treat diseases faster
Iterative AI and lab cycles for biologics development and validation
Uses reverse immunology to find novel targets for drug creation
Unlock access to complete
Unlock access to complete
Funding Insights of Denovium
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Denovium
Denovium has secured backing from 1 investor. Prominent investors backing the company include AbSci. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
AI-based technology is used for recombinant protein production in therapeutics.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Denovium
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Denovium
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Denovium Comparisons
Competitors of Denovium
Denovium operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zephyr AI, Precisionlife, Chemify, Transaction Data Systems and RevolKa, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of AI development services for biopharma sector
|
|
| domain | founded_year | HQ Location |
AI-enabled platforms for drug discovery and precision medicine are developed.
|
|
| domain | founded_year | HQ Location |
Software development services are provided for pharmaceutical and materials research.
|
|
| domain | founded_year | HQ Location |
Software development services are provided to the biopharma sector.
|
|
| domain | founded_year | HQ Location |
AI development services are provided for the biopharma sector.
|
|
| domain | founded_year | HQ Location |
Drug discovery and design are enabled by a cloud-based platform.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Denovium
When was Denovium founded?
Denovium was founded in 2018.
Where is Denovium located?
Denovium is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
What does Denovium do?
Denovium was founded in 2018 and is based in San Diego, United States. AI-driven methods and solutions are developed for the biopharma sector. Operations focus on applying artificial intelligence to enhance research and development processes in biotechnology and pharmaceuticals. Services include computational tools tailored for drug discovery and data analysis. The company is led by co-founder Imad Ajjawi.
Who are the top competitors of Denovium?
What products or services does Denovium offer?
Denovium offers Integrated Drug Creation Platform, AI Drug Creation, and AI Target Discovery.
Who are Denovium's investors?
Denovium has 1 investor. Key investors include AbSci.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.